Trial
NCT03579446
Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
M.D. Anderson Cancer Center
Collaborators
National Cancer Institute (NCI)
Condition
Hematopoietic and Lymphoid Cell Neoplasm
Intervention
Hydrocodone
Why stopped
\<75% participation
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-03